NCT07095894View on ClinicalTrials.gov

A RCT of Spectacles With Aspherical Lenslets vs Low-Dose Atropine for Treatment of Myopia

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

348

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 1, 2028

Study Completion Date

May 31, 2029

Conditions
Myopia
Interventions
DRUG

Atropine

Daily 0.05% atropine eyedrops

DEVICE

Spectacles with HAL

Spectacle lenses with highly aspherical lenslets (HAL)

DRUG

Placebo Eyedrops

Daily placebo eyedrops

Sponsors
All Listed Sponsors
lead

Jaeb Center for Health Research

OTHER